Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
骨髓间充质干细胞治疗肾移植后慢性抗体介导排斥反应的疗效和安全性——单臂、两剂量方案 I/II 期研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.662441
Wei Yongcheng, Chen Xiaoyong, Zhang Huanxi, Su Qun, Peng Yanwen, Fu Qian, Li Jun, Gao Yifang, Li Xirui, Yang Shicong, Ye Qianyu, Huang Huiting, Deng Ronghai, Li Gang, Xu Bowen, Wu Chenglin, Wang Jiali, Zhang Xiaoran, Su Xiaojun, Liu Longshan, Xiang Andy Peng, Wang Changxi